583 news items
Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy
RENB
24 May 24
from both executive boards. This collaboration would bring together Renovaro's proprietary cancer vaccine technology
Critical Insights From BioNTech Analyst Ratings: What You Need To Know
BNTX
24 May 24
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy
YS Biopharma Announces Name Change to LakeShore Biopharma
YS
24 May 24
, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
SNGX
24 May 24
) technology, dusquetide (SGX942) for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer, and (SGX945) in Behçet's
Elicio Therapeutics Announces Preliminary Data from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting
ELTX
23 May 24
announced preliminary data from the ongoing AMPLIFY-7P Phase 1a study of its off-the-shelf investigational therapeutic cancer vaccine candidate, ELI
kt7di
BMY
23 May 24
-sponsored studies, and collaborations showcase results spanning approximately 25 cancer types and serious blood disorders
if4qnfc5mnnbps3swfwzd6
PGEN
23 May 24
respiratory papillomatosis patients" by Scott M. Norberg, DO, Associate Research Physician, Center for Immuno-Oncology, Center for Cancer
f1an7vbs
LEGN
23 May 24
institutional guidelines for the vaccination and management of immunocompromised patients with COVID-19
cqd2jc55of4wqdhu8pzt9xd
CADL
23 May 24
stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced topline overall
uuxb4h7tnkcluxtk9f48ik ub
EVAX
23 May 24
it will present positive immune data form its ongoing EVX-01 Phase 2 study. The study assesses the personalized cancer vaccine EVX-01 in combination with anti
kxz 4v106ei6c2zh7j3wzvnhm6v1i8bqf6o05e9duvwcg81u0lr2tea
23 May 24
-vaccination syndrome, the FLCCC has since broadened its scope with the development of various
rev96lg739ubdw0cprhi7zhkn0xwk
PFE
23 May 24
declining investor interest and diminishing sales from its COVID-19 vaccine and treatments.
Also Read
8iwj0e5 o9vdhro26lrzoiyq9ixm6moxb0rav1pkz3si1i0nw1142xz8
23 May 24
(Upstream, Downstream) Application (Monoclonal Antibodies, Vaccines, Plasma Fractionation, R&D) End User—Global Forecast to 2031", published
7gwgdf19 62cnp3abfqysqx5h0ogxy1c5njt62fm7
23 May 24
, Tiziana Life Sciences, Abivax, Arena Pharmaceuticals, Cytocom, HAV Vaccines Ltd, Enzo Biochem Inc., Stero Biotechs, Reistone Biopharma Company
zkvpgpyxf06lekoaqhavjwbt4k7agtpmugn2lh hbbizsxfexr4t892w
23 May 24
-ARSTM, which enable personalized or universal neoantigen cancer vaccine and novel antibody drug prediction, respectively. These cutting-edge solutions
v00wbstsbomrnyu
23 May 24
of vaccines and therapeutics, and the Ontario Institute for Cancer Research (OICR
rmakf98hdi3j9kukmnw
23 May 24
of vaccines and therapeutics, and the Ontario Institute for Cancer Research (OICR
8j67x2arlq10a3
IOBT
23 May 24
company developing novel, immune-modulating therapeutic cancer vaccines based on its T-win® platform, announced today that Mai-Britt
dp9o70eytv9ghs e5utygeq3k7
23 May 24
and accelerate clinical milestones leading to greater impact for patients living with cancer and autoimmune diseases. The combined company is supported
zzqjfwos61lg8fc r1b6t3d
PFE
23 May 24
and diminishing sales from its COVID-19 vaccine and treatments.
Pfizer’s shares rose 2.6% to $29.30 in afternoon trading but remain down